Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres

被引：0

作者：

Jin-Kyoung Shim

Seonah Choi

Seon-Jin Yoon

Ran Joo Choi

Junseong Park

Eun Hee Lee

Hye Joung Cho

Suji Lee

Wan-Yee Teo

Ju Hyung Moon

Hyun Sil Kim

Eui Hyun Kim

Jae-Ho Cheong

Jong Hee Chang

Jong In Yook

Seok-Gu Kang

机构：

[1] Severance Hospital,Department of Neurosurgery, Brain Tumor Center

[2] Yonsei University College of Medicine,Precision Medicine Research Center, College of Medicine

[3] Brain Tumor Translational Research Laboratory,Department of Medical Science, BK21 Plus Project for Medical Science

[4] Severance Biomedical Research Institute,Department of Oral Pathology

[5] Yonsei University College of Medicine,Department of Surgery, BK21 Plus Project for Medical Science

[6] The Catholic University of Korea,Departments of Medical Science

[7] Yonsei University College of Medicine,undefined

[8] Cancer and Stem Cell Biology Program,undefined

[9] Duke-NUS Medical School,undefined

[10] Institute of Molecular and Cell Biology,undefined

[11] A*STAR,undefined

[12] Yonsei University College of Dentistry,undefined

[13] Yonsei University College of Medicine,undefined

[14] Yonsei University Graduate School,undefined

来源：

Cancer Cell International | / 22卷

关键词：

Etomoxir; Fatty acid oxidation; Glioblastoma; Temozolomide; Tumorsphere;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 4 条